Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4286573
Max Phase: Preclinical
Molecular Formula: C24H24F3N9O3S
Molecular Weight: 575.58
Molecule Type: Small molecule
Associated Items:
ID: ALA4286573
Max Phase: Preclinical
Molecular Formula: C24H24F3N9O3S
Molecular Weight: 575.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNC(=O)Nc1cc(-c2nc(C(F)(F)F)cs2)c(-c2cc(-c3n[nH]c(=O)o3)cnc2N2CCC(N)CC2)cn1
Standard InChI: InChI=1S/C24H24F3N9O3S/c1-2-29-22(37)33-18-8-15(21-32-17(11-40-21)24(25,26)27)16(10-30-18)14-7-12(20-34-35-23(38)39-20)9-31-19(14)36-5-3-13(28)4-6-36/h7-11,13H,2-6,28H2,1H3,(H,35,38)(H2,29,30,33,37)
Standard InChI Key: UCFIUPFZVAQTSV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 575.58 | Molecular Weight (Monoisotopic): 575.1675 | AlogP: 3.70 | #Rotatable Bonds: 6 |
Polar Surface Area: 167.95 | Molecular Species: BASE | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.25 | CX Basic pKa: 10.02 | CX LogP: 1.93 | CX LogD: 1.71 |
Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.27 | Np Likeness Score: -1.40 |
1. Ho SY, Wang W, Ng FM, Wong YX, Poh ZY, Tan SWE, Ang SH, Liew SS, Joyner Wong YS, Tan Y, Poulsen A, Pendharkar V, Sangthongpitag K, Manchester J, Basarab G, Hill J, Keller TH, Cherian J.. (2018) Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria., 157 [PMID:30125722] [10.1016/j.ejmech.2018.08.025] |
Source(1):